Pascal Finetti

15.8k total citations · 1 hit paper
175 papers, 9.8k citations indexed

About

Pascal Finetti is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Pascal Finetti has authored 175 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Oncology, 79 papers in Molecular Biology and 71 papers in Cancer Research. Recurrent topics in Pascal Finetti's work include Cancer Genomics and Diagnostics (29 papers), Breast Cancer Treatment Studies (26 papers) and Cancer Cells and Metastasis (23 papers). Pascal Finetti is often cited by papers focused on Cancer Genomics and Diagnostics (29 papers), Breast Cancer Treatment Studies (26 papers) and Cancer Cells and Metastasis (23 papers). Pascal Finetti collaborates with scholars based in France, United States and Belgium. Pascal Finetti's co-authors include François Bertucci, Daniel Birnbaum, Patrice Viens, Nathalie Cervera, Emmanuelle Charafe‐Jauffret, José Adélaı̈de, Jocelyne Jacquemier, Émilie Mamessier, Christophe Ginestier and Max Chaffanet and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Pascal Finetti

171 papers receiving 9.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature

2009 935 citations Emmanuelle Charafe‐Jauffret, Christophe Ginestier et al. Cancer Research profile →

Peers

Countries citing papers authored by Pascal Finetti

Since Specialization

Citations

This map shows the geographic impact of Pascal Finetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Finetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Finetti more than expected).

Fields of papers citing papers by Pascal Finetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Finetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Finetti. The network helps show where Pascal Finetti may publish in the future.

Co-authorship network of co-authors of Pascal Finetti

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Finetti. A scholar is included among the top collaborators of Pascal Finetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Finetti. Pascal Finetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Deciphering Folate Receptor alphaGene Expression and mRNA Signatures in Ovarian Cancer: Implications for Precision Therapies 2024 ·International Journal of Molecular Sciences ·Maria Kfoury, Pascal Finetti, Émilie Mamessier, François Bertucci, Renaud Sabatier	0
2	PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular Carcinoma 2023 ·Cancers ·David Jérémie Birnbaum, (unknown), (unknown), (unknown), Pascal Finetti, Olivier Cabaud, (unknown), (unknown), Emilie Denicolaï, François Bertucci, Émilie Mamessier	4
3	Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network 2023 ·Journal of Translational Medicine ·(unknown), Claudia Lefeuvre‐Plesse, Alejandra Martínez, Céline Chauleur, Alain Lortholary, Laure Favier, Anne‐Sophie Bats, Arnaud Guillé, José Adélaı̈de, Pascal Finetti, (unknown), Magali Provansal, Émilie Mamessier, François Bertucci, Isabelle Ray‐Coquard, Renaud Sabatier	6
4	ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines 2023 ·Pharmaceutics ·(unknown), José Adélaı̈de, Thi Khanh Le, (unknown), Pascal Finetti, Clément Paris, Arnaud Guillé, François Bertucci, Daniel Birnbaum, Palma Rocchi, Max Chaffanet	3
5	The serine/threonine kinase MINK1 directly regulates the function of promigratory proteins 2022 ·Journal of Cell Science ·Avais M. Daulat, (unknown), Stéphane Audebert, Małgorzata Kowalczewska, (unknown), Pascal Finetti, François Bertucci, Luc Camoin, Jean‐Paul Borg	6
6	TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT 2022 ·EMBO Molecular Medicine ·Alexandre de Nonneville, Sébastien Salas, François Bertucci, Alexander P. Sobinoff, José Adélaı̈de, Arnaud Guillé, Pascal Finetti, Jane R. Noble, (unknown), Max Chaffanet, (unknown), Hilda A. Pickett, Corinne Bouvier, Daniel Birnbaum, Roger R. Reddel, Vincent Géli	27
7	Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients 2022 ·Cancers ·Alexia Lopresti, Claire Acquaviva, Laurys Boudin, Pascal Finetti, Séverine Garnier, Anaïs Aulas, (unknown), Olivier Cabaud, Arnaud Guillé, Alexandre de Nonneville, (unknown), Emilie Denicolaï, Jihane Pakradouni, Anthony Gonçalvès, Daniel Birnbaum, François Bertucci, Émilie Mamessier	6
8	Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma 2021 ·Clinical Cancer Research ·David Jérémie Birnbaum, (unknown), Pascal Finetti, Charles Vanderburg, Anupriya S. Kulkarni, Azfar Neyaz, Thomas Hank, Eric C. Tai, Vikram Deshpande, François Bertucci, Daniel Birnbaum, Keith D. Lillemoe, Andrew L. Warshaw, Mari Mino–Kenudson, Carlos Fernández‐del Castillo, David T. Ting, Andrew S. Liss	11
9	Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy 2021 ·Cancers ·Gayathri R. Devi, Pascal Finetti, Michael A. Morse, (unknown), Alexandre de Nonneville, Steven Van Laere, Jesse D. Troy, Joseph Geradts, Shannon J. McCall, François Bertucci	22
10	Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion 2021 ·Molecular Oncology ·Emilly S. Villodre, Xiaoding Hu, Richard Larson, Pascal Finetti, (unknown), (unknown), Shane R. Stecklein, Ginette S. Santiago-Sánchez, Savitri Krishnamurthy, Juhee Song, Xiaoping Su, Naoto T. Ueno, Debu Tripathy, Steven Van Laere, François Bertucci, Pablo E. Vivas‐Mejía, Wendy A. Woodward, Bisrat G. Debeb	27
11	Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis 2017 ·OncoImmunology ·Wouter Hendrickx, Ines Simeone, Samreen Anjum, Younes Mokrab, François Bertucci, Pascal Finetti, Giuseppe Curigliano, Barbara Seliger, Luigi Cerulo, Sara Tomei, Lucia Gemma Delogu, Cristina Maccalli, Ena Wang, Lance D. Miller, Francesco M. Marincola, Michele Ceccarelli, Davide Bedognetti	128
12	EFA6B Antagonizes Breast Cancer 2014 ·Cancer Research ·Joséphine Zangari, Mariagrazia Partisani, François Bertucci, Julie Milanini, Ghislain Bidaut, Carole Berruyer-Pouyet, Pascal Finetti, Élodie Long-Mira, Frédéric Brau, Olivier Cabaud, Bruno Chetaille, Daniel Birnbaum, Marc Lopez, Paul Hofman, Michel Franco, Frédéric Luton	21
13	The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression 2013 ·Clinical Cancer Research ·(unknown), Julien Wicinski, Olivier Cabaud, Yves Toiron, Pascal Finetti, Emmanuelle Josselin, Hélène Lelièvre, Laurence Kraus‐Berthier, Stéphane Depil, François Bertucci, Yves Collette, Daniel Birnbaum, Emmanuelle Charafe‐Jauffret, Christophe Ginestier	113
14	Contrasted Outcomes to Gefitinib on Tumoral IGF1R Expression in Head and Neck Cancer Patients Receiving Postoperative Chemoradiation (GORTEC Trial 2004-02) 2012 ·Clinical Cancer Research ·Juliette Thariat, René‐Jean Bensadoun, Marie-Christine Étienne-Grimaldi, Dominique Grall, Frédérique Penault‐Llorca, O. Dassonville, François Bertucci, Anne Cayre, D. De Raucourt, Lionnel Geoffrois, Pascal Finetti, P. Giraud, S. Racadot, S. Morinière, Anne Sudaka, Ellen Van Obberghen‐Schilling, G. Milano	26
15	Human Breast Tumor Cells Induce Self-Tolerance Mechanisms to Avoid NKG2D-Mediated and DNAM-Mediated NK Cell Recognition 2011 ·Cancer Research ·Émilie Mamessier, Aude Sylvain, François Bertucci, Rémy Castellano, Pascal Finetti, Gilles Houvenaeghel, (unknown), Daniel Birnbaum, Alessandro Moretta, D Olive	100
16	Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature breakdown → 2009 ·Cancer Research ·Emmanuelle Charafe‐Jauffret, Christophe Ginestier, Flora Iovino, Julien Wicinski, Nathalie Cervera, Pascal Finetti, Min-Hee Hur, Mark E. Diebel, Florence Monville, Julie Dutcher, Marty Brown, Patrice Viens, Luc Xerri, François Bertucci, Giorgio Stassi, Gabriela Dontu, Daniel Birnbaum, Max S. Wicha	935
17	Sixteen–Kinase Gene Expression Identifies Luminal Breast Cancers with Poor Prognosis 2008 ·Cancer Research ·Pascal Finetti, Nathalie Cervera, Emmanuelle Charafe‐Jauffret, Christian Chabannon, Colette Charpin, Max Chaffanet, Jocelyne Jacquemier, Patrice Viens, Daniel Birnbaum, François Bertucci	96
18	Integrated Profiling of Basal and Luminal Breast Cancers 2007 ·Cancer Research ·José Adélaı̈de, Pascal Finetti, Ismahane Bekhouche, (unknown), Jeannine Geneix, Fabrice Sircoulomb, Emmanuelle Charafe‐Jauffret, Nathalie Cervera, Jérôme Desplans, Daniel Parzy, Eric Schoenmakers, Patrice Viens, J Jacquemier, Daniel Birnbaum, François Bertucci, Max Chaffanet	221
19	Gene Expression Profiling Shows Medullary Breast Cancer Is a Subgroup of Basal Breast Cancers 2006 ·Cancer Research ·François Bertucci, Pascal Finetti, Nathalie Cervera, Emmanuelle Charafe‐Jauffret, Émilie Mamessier, José Adélaı̈de, Stéphane Debono, Gilles Houvenaeghel, D Maraninchi, Patrice Viens, Colette Charpin, Jocelyne Jacquemier, Daniel Birnbaum	218
20	Prognosis and Gene Expression Profiling of 20q13-Amplified Breast Cancers 2006 ·Clinical Cancer Research ·Christophe Ginestier, Nathalie Cervera, Pascal Finetti, Séverine Esteyriès, Benjamin Esterni, José Adélaı̈de, Luc Xerri, Patrice Viens, Jocelyne Jacquemier, Emmanuelle Charafe‐Jauffret, Max Chaffanet, Daniel Birnbaum, François Bertucci	107

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact